We are closer than ever to finding new treatments for Parkinson’s. We believe our pioneering and collaborative approach to research, working with inspirational scientists across the world and funding innovative projects, will lead to a cure for Parkinson’s once and for all. 

Research projects

Find out more about the drugs being studied in our research projects, including preclinical and clinical research.

Find out more
Research news

Read our latest Parkinson’s research updates, curated by our research team.

Find out more
Our approach to research

Find out how our unique approach to research and drug prioritisation is accelerating the search for a cure.

Find out more
Research events

Join one of our research events for the opportunity to learn more about Parkinson’s and hear the latest research updates.

Find out more
The International Linked Clinical Trials Programme (iLCT)

Learn about our innovative iLCT programme which connects researchers across the world to evaluate some of the most promising drugs for disease-modifying treatments for Parkinson’s.

Find out more
The International Linked Clinical Trials (iLCT) Committee

The drug selection process in our International Linked Clinical Trials (iLCT) programme is governed and evaluated by a committee of world leading scientists, physicians and advocates, all experts in the field of Parkinson’s research.

Find out more
The Research Committee

Our research committee interrogates new proposals and analyses research reports to ensure that the science is robust and progressive and ultimately, will benefit those living with Parkinson’s.

Find out more